First-line vascular endothelial growth factor inhibitors for advanced renal cell carcinoma and the impact of new agents entering the treatment paradigm.
Overview
publication date
- July 30, 2017
published in
- BJU international Journal
Research
keywords
- Carcinoma, Renal Cell
- Protein Kinase Inhibitors
- Receptors, Vascular Endothelial Growth Factor
Identity
Scopus Document Identifier
- 85026477612
Digital Object Identifier (DOI)
- 10.1111/bju.13954
PubMed ID
- 28688143
Additional Document Info
has global citation frequency
volume
- 120
issue
- 6